{"entity":{"type":"insider","cik":"0001662520","url":"/insider/0001662520","json_url":"/insider/0001662520.json","name":"Castellanos Elaine","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":16,"first":"2018-07-25","last":"2021-06-09","span_basis":"filed_date"},"name_variants":[{"name":"Castellanos Elaine","source":"filing","n_filings":16,"first_seen":"2018-07-25","last_seen":"2021-06-09"}],"transactions":[{"id":4668360,"accession":"0001209191-21-039175","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-039175","line_url":"/filing/0001209191-21-039175","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8454.0,"shares_display":"8,454","price_per_share":141.90089744499645,"price_display":"141.90","price_state":"stated","total_value":1199630.187,"total_display":"1,199,630.19","total_whole":"1,199,630","shares_owned_after":15100.0,"shares_owned_after_display":"15,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-09","scope":"insider","n_lines":2},{"id":4668349,"accession":"0001209191-21-039175","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-039175","line_url":"/filing/0001209191-21-039175","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1546.0,"shares_display":"1,546","price_per_share":146.75462470892626,"price_display":"146.75","price_state":"stated","total_value":226882.6498,"total_display":"226,882.65","total_whole":"226,883","shares_owned_after":15182.0,"shares_owned_after_display":"15,182","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider","n_lines":2},{"id":5292264,"accession":"0001209191-21-036326","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-036326","line_url":"/filing/0001209191-21-036326#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":124.547,"price_display":"124.55","price_state":"stated","total_value":1245470.0,"total_display":"1,245,470.00","total_whole":"1,245,470","shares_owned_after":14546.0,"shares_owned_after_display":"14,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-27","scope":"insider"},{"id":3019108,"accession":"0001209191-20-058260","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-058260","line_url":"/filing/0001209191-20-058260#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":176.02,"price_display":"176.02","price_state":"stated","total_value":616070.0,"total_display":"616,070.00","total_whole":"616,070","shares_owned_after":15146.0,"shares_owned_after_display":"15,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":3089595,"accession":"0001209191-20-033270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-033270","line_url":"/filing/0001209191-20-033270#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":143.97,"price_display":"143.97","price_state":"stated","total_value":287940.0,"total_display":"287,940.00","total_whole":"287,940","shares_owned_after":15146.0,"shares_owned_after_display":"15,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-01","scope":"insider"},{"id":2643851,"accession":"0001209191-20-014386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-014386","line_url":"/filing/0001209191-20-014386#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":194.32,"price_display":"194.32","price_state":"stated","total_value":388640.0,"total_display":"388,640.00","total_whole":"388,640","shares_owned_after":15146.0,"shares_owned_after_display":"15,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-02","scope":"insider"},{"id":8168677,"accession":"0001209191-19-058681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-058681","line_url":"/filing/0001209191-19-058681#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":194.24,"price_display":"194.24","price_state":"stated","total_value":388480.0,"total_display":"388,480.00","total_whole":"388,480","shares_owned_after":15146.0,"shares_owned_after_display":"15,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-03","scope":"insider"},{"id":8241016,"accession":"0001209191-19-054468","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-054468","line_url":"/filing/0001209191-19-054468#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":200.0,"price_display":"200.00","price_state":"stated","total_value":800000.0,"total_display":"800,000.00","total_whole":"800,000","shares_owned_after":15146.0,"shares_owned_after_display":"15,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-28","filed_date":"2019-10-30","scope":"insider"},{"id":8028622,"accession":"0001209191-19-054248","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-054248","line_url":"/filing/0001209191-19-054248#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (VP, Chief Accounting Officer)","role_mark":"O","role_mark_label":"Officer (VP, Chief Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Chief Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":190.0,"price_display":"190.00","price_state":"stated","total_value":380000.0,"total_display":"380,000.00","total_whole":"380,000","shares_owned_after":15146.0,"shares_owned_after_display":"15,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-25","filed_date":"2019-10-28","scope":"insider"},{"id":7928532,"accession":"0001209191-19-053681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-053681","line_url":"/filing/0001209191-19-053681#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":170.0,"price_display":"170.00","price_state":"stated","total_value":340000.0,"total_display":"340,000.00","total_whole":"340,000","shares_owned_after":11933.0,"shares_owned_after_display":"11,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-18","filed_date":"2019-10-21","scope":"insider"},{"id":8320825,"accession":"0001209191-19-053437","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-053437","line_url":"/filing/0001209191-19-053437","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14000.0,"shares_display":"14,000","price_per_share":147.58857142857144,"price_display":"147.59","price_state":"stated","total_value":2066240.0,"total_display":"2,066,240.00","total_whole":"2,066,240","shares_owned_after":13933.0,"shares_owned_after_display":"13,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-17","scope":"insider","n_lines":2},{"id":8240912,"accession":"0001209191-19-053131","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-053131","line_url":"/filing/0001209191-19-053131#line-3","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":105.0,"price_display":"105.00","price_state":"stated","total_value":315000.0,"total_display":"315,000.00","total_whole":"315,000","shares_owned_after":11933.0,"shares_owned_after_display":"11,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-14","filed_date":"2019-10-15","scope":"insider"},{"id":8240483,"accession":"0001209191-19-049007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049007","line_url":"/filing/0001209191-19-049007#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":170000.0,"total_display":"170,000.00","total_whole":"170,000","shares_owned_after":2138.0,"shares_owned_after_display":"2,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-06","filed_date":"2019-09-10","scope":"insider"},{"id":7927061,"accession":"0001209191-19-034656","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-034656","line_url":"/filing/0001209191-19-034656#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":85.2,"price_display":"85.20","price_state":"stated","total_value":170400.0,"total_display":"170,400.00","total_whole":"170,400","shares_owned_after":2138.0,"shares_owned_after_display":"2,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-03","filed_date":"2019-06-05","scope":"insider"},{"id":8344778,"accession":"0001209191-19-024119","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-024119","line_url":"/filing/0001209191-19-024119#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":90.17,"price_display":"90.17","price_state":"stated","total_value":180340.0,"total_display":"180,340.00","total_whole":"180,340","shares_owned_after":2138.0,"shares_owned_after_display":"2,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-08","filed_date":"2019-04-09","scope":"insider"},{"id":7875872,"accession":"0001209191-19-017824","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-017824","line_url":"/filing/0001209191-19-017824#line-2","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3588.0,"shares_display":"3,588","price_per_share":102.0,"price_display":"102.00","price_state":"stated","total_value":365976.0,"total_display":"365,976.00","total_whole":"365,976","shares_owned_after":2138.0,"shares_owned_after_display":"2,138","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-05","filed_date":"2019-03-07","scope":"insider"},{"id":6803310,"accession":"0001209191-18-043879","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-043879","line_url":"/filing/0001209191-18-043879","is_derivative":false,"issuer_cik":"0001358762","issuer_name":"REATA PHARMACEUTICALS INC","issuer_ticker":"RETA","issuer_name_source":null,"issuer_url":"/issuer/0001358762","owner_cik":"0001662520","owner_name":"Castellanos Elaine","owner_display_name":"Castellanos Elaine","owner_url":"/insider/0001662520","role":"Officer (Principal Accounting Officer)","role_mark":"O","role_mark_label":"Officer (Principal Accounting Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Principal Accounting Officer","security_title":"Class A common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7336.0,"shares_display":"7,336","price_per_share":50.81297709923664,"price_display":"50.81","price_state":"stated","total_value":372764.0,"total_display":"372,764.00","total_whole":"372,764","shares_owned_after":140.0,"shares_owned_after_display":"140","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-25","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001358762","name":"REATA PHARMACEUTICALS INC","url":"/issuer/0001358762","role":"Officer (VP, Chief Accounting Officer)","n_filings":16,"first_seen":"2018-07-25","last_seen":"2021-06-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001662520","retrieved_at":"2026-08-25T12:24:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}